about
Challenges and strategies in anti-cancer nanomedicine development: An industry perspectivePharmacological Intervention in Hepatic Stellate Cell Activation and Hepatic FibrosisNoninvasive Imaging of Nanomedicines and Nanotheranostics: Principles, Progress, and Prospects.The necroptosis-inducing kinase RIPK3 dampens adipose tissue inflammation and glucose intolerance.Quantitative Micro-Computed Tomography Imaging of Vascular Dysfunction in Progressive Kidney DiseasesUltrasound-mediated drug delivery to the brain: principles, progress and prospectsPhotoacoustic imaging of tumor targeting with riboflavin-functionalized theranostic nanocarriers.Enhancing Tumor Penetration of Nanomedicines.Squamous Cell Carcinoma Xenografts: Use of VEGFR2-targeted Microbubbles for Combined Functional and Molecular US to Monitor Antiangiogenic Therapy Effects.Sonoporation enhances liposome accumulation and penetration in tumors with low EPR.Theranostic USPIO-Loaded Microbubbles for Mediating and Monitoring Blood-Brain Barrier PermeationNanoparticles for imaging: top or flop?Recent advances in molecular, multimodal and theranostic ultrasound imaging.The Theranostic Path to Personalized NanomedicineNon-invasive imaging for studying anti-angiogenic therapy effects.CCL2-dependent infiltrating macrophages promote angiogenesis in progressive liver fibrosis.Absolute MR thermometry using nanocarriers.Enhanced in vitro and in vivo cellular imaging with green tea coated water-soluble iron oxide nanocrystals.Micro-computed tomography (μCT) as a novel method in ecotoxicology--determination of morphometric and somatic data in rainbow trout (Oncorhynchus mykiss).Synthesis and characterization of HE-24.8: a polymeric contrast agent for magnetic resonance angiography.Imalytics Preclinical: Interactive Analysis of Biomedical Volume DataCancer nanomedicines: oversold or underappreciated?Targeting cellular and microenvironmental multidrug resistance.Characterizing EPR-mediated passive drug targeting using contrast-enhanced functional ultrasound imagingTargeting iron metabolism in drug discovery and deliveryPEG-pHPMAm-based polymeric micelles loaded with doxorubicin-prodrugs in combination antitumor therapy with oncolytic vaccinia viruses.Decationized polyplexes as stable and safe carrier systems for improved biodistribution in systemic gene therapyRhodamine-loaded intercellular adhesion molecule-1-targeted microbubbles for dual-modality imaging under controlled shear stresses.Core-Crosslinked Polymeric Micelles: Principles, Preparation, Biomedical Applications and Clinical TranslationFluorescently labeled microbubbles for facilitating translational molecular ultrasound studies.Noninvasive molecular ultrasound monitoring of vessel healing after intravascular surgical procedures in a preclinical setup.Fluorophore labeling of core-crosslinked polymeric micelles for multimodal in vivo and ex vivo optical imaging.Complete Regression of Xenograft Tumors upon Targeted Delivery of Paclitaxel via Π-Π Stacking Stabilized Polymeric Micelles.Role of PP2Calpha in cell growth, in radio- and chemosensitivity, and in tumorigenicityTumour-targeted nanomedicines: principles and practice.Role of type 2C protein phosphatases in growth regulation and in cellular stress signaling.Micro-CT imaging of tumor angiogenesis: quantitative measures describing micromorphology and vascularization.Improving the efficacy of combined modality anticancer therapy using HPMA copolymer-based nanomedicine formulations.Theranostic nanomedicine.Physicochemical and biological aspects of macrophage-mediated drug targeting in anti-microbial therapy.
P50
Q26748018-098DEB0B-745C-47E4-9F0F-D9A1D7E62688Q26768588-D796AAE9-7CF4-4A86-BE55-9DA6DAD4559BQ26822871-2D09224D-801B-4F9E-A742-012ACE8E80E3Q27313354-3AEC9B92-4DEC-4013-9E66-52B455619FD6Q27342525-B9B618DF-D815-432B-B6CF-06141AC30BB7Q28067198-805A3E24-47E6-4E87-9C5B-8C4B577D5E6EQ30355156-293D4D72-A08D-460A-B45A-9B6297FE5A4CQ30356887-E999F727-AEBE-4524-B6F8-172D5806982BQ30357817-0E54167D-5289-4B9A-82F6-015517984871Q30358121-BABD5AE1-570E-4DA8-80B7-7D251F7E7622Q30417969-57CF0DEC-878E-47A9-B95F-90C5A16E4EE9Q30429119-61CCB6E1-D3DB-4E2B-962E-20AEBC990F9CQ30436709-5DB526A9-5B23-4F59-B270-E87728AC9D44Q30437998-5A33D011-7CB2-472C-9CAC-F741E69A8BF1Q30447988-91C4DDCF-264C-4477-825A-E8F80D7B3423Q30596736-C6AA3911-6A13-4955-83BB-778E86429BFAQ30794865-101D071B-15A0-480A-8631-799418A5C49EQ30902260-63FCA4CE-3C83-4FB3-9E21-AB95EE42B07DQ31025694-4384A03A-50CE-4CF2-9F32-1D6BA8BBB3C4Q31029857-BDF8B567-C530-4B47-B92D-7A6429046C7FQ31048680-8B8D2DB3-5BF7-49B3-83BA-C072F41FFAFFQ33602272-B48FDD42-0041-405E-BCB7-52542C809221Q33602284-A0D4DC6F-5E2B-4AB7-9DD3-3D20D25CE161Q33651804-C7499E57-E801-482C-8FAC-FFB79D69DF1AQ33757232-6A1C070C-50AC-434C-B1C0-8CCFD9B6D413Q34403672-8B04291D-D96B-4774-A9D8-DEDF9EB769A3Q34626943-18A7E5BA-ADEE-4F87-BDAB-A953997BF00AQ34987341-9A2432C4-41FA-49B9-8527-428CEEA3F655Q35438759-EF5059E1-15ED-4876-B307-B1E4E62774E6Q35580731-E22CE2A4-9BC5-441C-AF24-994D9E650707Q35594690-9BA6805C-46C1-4F47-87DE-B3657CAA4FA4Q35619572-C3B44A51-D0EC-4A13-BDF2-116D45ECB64DQ35911710-DDA7160D-A93E-403C-8628-36530B2F81BEQ36178123-C82D3CDF-1FC1-4F35-BF5B-AFEC3FD8B689Q36858135-5D7C391F-67CC-4AC3-9BAE-11D3FD7480FEQ37027389-E5515CD7-5076-4120-A363-30D13A92E1A7Q37575598-ED1B0E56-F9C0-4E6A-9B54-659FC95EF442Q37642119-F84A93EA-B8C4-438A-8AE7-257EA93D7004Q37872285-A8DC8AC9-FCF0-4F14-ADD0-088EFDABAF04Q37883474-C67CBAF3-DDD2-4D56-A090-8D87EA069B09
P50
description
researcher ORCID ID = 0000-0002-1090-6805
@en
wetenschapper
@nl
name
Twan Lammers
@ast
Twan Lammers
@en
Twan Lammers
@es
Twan Lammers
@nl
type
label
Twan Lammers
@ast
Twan Lammers
@en
Twan Lammers
@es
Twan Lammers
@nl
prefLabel
Twan Lammers
@ast
Twan Lammers
@en
Twan Lammers
@es
Twan Lammers
@nl
P106
P1153
9633072700
P31
P496
0000-0002-1090-6805